Connection
John Rumsfeld to Secondary Prevention
This is a "connection" page, showing publications John Rumsfeld has written about Secondary Prevention.
|
|
Connection Strength |
|
 |
|
 |
|
0.165 |
|
|
|
-
Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009 Mar 04; 301(9):937-44.
Score: 0.073
-
Ho PM, Fihn SD, Wang L, Bryson CL, Lowy E, Maynard C, Magid DJ, Peterson ED, Jesse RL, Rumsfeld JS. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J. 2007 Nov; 154(5):846-51.
Score: 0.066
-
Byrd JB, Maddox TM, O'Donnell CI, Grunwald GK, Bhatt DL, Tsai TT, Rumsfeld JS, Ho PM. Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: insights from the Veterans Affairs CART Program. Am Heart J. 2014 Sep; 168(3):340-5.
Score: 0.026